LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $111,000 | -90.3% | 53,152 | -81.6% | 0.00% | -83.3% |
Q4 2021 | $1,141,000 | -18.0% | 289,479 | +0.1% | 0.01% | -14.3% |
Q3 2021 | $1,391,000 | +10.7% | 289,154 | +5.6% | 0.01% | 0.0% |
Q2 2021 | $1,256,000 | +24.5% | 273,734 | +59.3% | 0.01% | +16.7% |
Q1 2021 | $1,009,000 | +79.9% | 171,873 | +4.8% | 0.01% | +100.0% |
Q4 2020 | $561,000 | +137.7% | 164,051 | +0.3% | 0.00% | +200.0% |
Q3 2020 | $236,000 | +114.5% | 163,577 | +197.4% | 0.00% | 0.0% |
Q2 2020 | $110,000 | -56.7% | 55,003 | -57.7% | 0.00% | -50.0% |
Q1 2020 | $254,000 | – | 130,122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |